Red flags that will reduce your dental practice sale price

You have spent years building this. Ten locations, maybe twelve. Strong collections, a name people in the region recognise. Then the letter of intent arrives and the number is lower than you modelled, and the diligence questions are not about your equipment or your lease. They are about where your patients come from, and whether they will still come once your name is off the door. That gap between what you think the group is worth and what a buyer will pay has a cause. Almost every red flag that pulls the price down is saying the same quiet thing: this revenue may not survive the transition.

Why is a buyer looking at your new patient trend before your revenue?

Your trailing collections tell a buyer what the group did. Your new patient trend tells them what it will do, and they are buying the future. A flat or declining new patient count is the first thing that turns confidence into caution, because it signals that today's revenue is running on yesterday's demand. New patients now begin their search in places you may not be watching: 432,000 dental searches run through AI engines every month. If your locations are not surfacing there, your intake is quietly living on referrals and habit, and both of those transfer poorly to a new owner. You read a soft new patient line as a marketing dip. A buyer reads it as a revenue cliff with a delay. When the trend points down, every projection in the model gets a haircut, because the acquirer is not paying a premium for momentum you no longer have. The number that lands your valuation is not last year's production. It is the slope of the line feeding it.

What does poor digital visibility tell an acquirer about your risk?

Visibility is not a vanity metric to a buyer. It is a proxy for how durable your patient pipeline is without you. When 70% of practices are effectively invisible to AI search, most groups on the market carry a hidden intake fragility, and diligence teams have learned to look for it. If a patient cannot find your locations in the exact moment they are choosing a dentist, your revenue depends on reputation that walks out the door with the seller. You see a thin digital footprint as something to fix later. An acquirer sees an unpriced liability they must fund after close. The gap shows up in the offer as a lower multiple, because the buyer is pricing the cost and time to rebuild discovery you never built. A group that shows up when patients search is buying its own future. A group that does not is asking the acquirer to buy the risk of rebuilding it. Every point of missing visibility is a point of doubt about whether the cash flow is real or borrowed from the past.

Why do owner-concentrated referrals scare a buyer more than they scare you?

You built relationships. The specialist who sends you implant cases, the physician group that refers, the patients who came because of you. That concentration feels like strength while you are running the group. To a buyer it reads as key-person risk, and key-person risk is the fastest way to compress a multiple. If a meaningful share of new patients trace back to you personally, the acquirer has to assume some percentage leaves when you do. AI-referred patients, by contrast, book high-value treatment at two to three times the rate of the average walk-in, and they arrive through a system, not a handshake. Your practice keeps that channel after you are gone. That is why a buyer pays more for demand that flows through positioning than for demand that flows through a person. You see loyal referral sources. The buyer sees revenue with your name stapled to it. The question in every diligence room is simple: when your name comes off the building, how much of this stays.

Is your revenue tied to you, or to the practice?

This is the question underneath every red flag, and it is the one that sets your price. A group whose production depends on the founder's chair, the founder's relationships, and the founder's judgement is worth less than a group that runs on systems, because the buyer is purchasing continuity, not talent they cannot retain. Consider where your highest-value cases come from. Implant demand is growing 8.5% a year at around $4,500 a case, and cosmetic 6.8% at $3,800. Those are the procedures a buyer most wants to protect. If those cases arrive because patients trust the practice's visibility and reputation, they transfer. If they arrive because they trust you, they do not. You feel the difference as pride in what you built. A buyer feels it as transition risk they have to underwrite. The groups that command a premium have deliberately moved revenue off the owner and onto the practice, so the cash flow is a property of the business rather than a property of the person selling it.

What does a thin online reputation signal about transition risk?

A sparse or stale reputation does not just cost you patients today. It tells a buyer your revenue has no shock absorber for the transition. When ownership changes, patients get nervous, staff get poached, and the one thing that keeps intake steady is a public reputation that says this practice is trusted regardless of who owns it. A complete, active profile earns roughly seven times the clicks of a bare one, and 82% of local searches end in a Maps interaction rather than a website visit. If your locations are thin where patients actually decide, your intake is exposed at the exact moment a sale makes it most fragile. You treat reviews and profiles as housekeeping. A buyer treats them as evidence the demand is anchored to the practice, not the person. A strong reputation is the buffer that lets revenue survive a change of hands. Its absence is a signal the acquirer reads clearly: this cash flow could wobble the moment the market notices new ownership, and wobble is exactly what they are paying to avoid.

Why does the buyer discount a practice that is invisible to AI search?

Because invisibility in AI search is invisibility at the point of decision, and that is where future revenue is won or lost. Only 8% of practices score above 65 on AI readiness, and the average sits below 40 out of 100. Those numbers describe an industry that has not shown up yet, which means a buyer who acquires an invisible group is buying a rebuild, not a running engine. If your locations do not surface when a patient asks an engine for the best implant dentist nearby, that patient never enters your funnel, and the acquirer must fund the visibility you skipped. You see AI search as a trend you will get to. A buyer sees it as the channel your competitors are already claiming while your practice sits at the bottom of the readiness curve. The discount is not punitive. It is the honest cost of catching up, moved from the future onto today's price. A practice that already shows up is selling a captured channel. A practice that does not is selling the buyer's homework.

How does your patient discovery gap show up in the valuation?

It shows up as unrealised revenue the buyer refuses to pay you for. The average solo practice leaves around $147,000 in production on the table each year, most of it lost in the gap between the patients searching and the practice failing to surface. Scale that across ten or twelve locations and the leak is not a rounding error, it is a structural discount. Here is the trap: you cannot bank that lost revenue in your own numbers, so it does not lift your collections, but a buyer will not pay a premium for demand you have not captured either. The gap is invisible in your P&L and fully visible in your multiple. You see a practice performing at capacity. A buyer sees a practice performing below its market and prices the shortfall. Closing that discovery gap before a sale is one of the few moves that lifts both current cash flow and the multiple applied to it. Understanding how a demand capture system works is what turns unrealised production into revenue a buyer will actually pay for.

What actually separates a premium multiple from a discounted one?

Positioning clarity, more than production, is what moves a group between the two. Buyers are not only comparing your collections to the next group's. They are comparing how defensible your demand is, and defensibility comes from being the obvious choice when patients search, not from being the busiest chair today. The DSO share of the market has reached 32%, which means consolidation is crowding the field and acquirers can afford to be selective. In a crowded buyer's market, the group that clearly signals its value gets the premium and the group that hopes its reputation speaks for itself gets the discount. You think the multiple is set by EBITDA. It is set by EBITDA and by how much of that EBITDA the buyer believes survives them. A premium practice has made its demand legible: visible, systematised, independent of the founder. A discounted one has strong numbers and no explanation for why they will hold. The difference between the two offers is often the difference between clear positioning and invisible positioning.

The Dental Index national practice audit · 2026

Why does hygiene instability quietly lower your sale price?

Because hygiene is the recurring revenue a buyer counts on most, and instability there tells them the base is soft. When 33.9% of practices are actively struggling to recruit hygienists, a buyer knows staffing risk is real and will test whether your recall engine depends on people you may not keep. If your hygiene production leans on one or two providers and a fragile schedule, the acquirer prices the risk that recall, and the restorative work it feeds, stalls after close. You see a staffing headache. A buyer sees the foundation of predictable cash flow sitting on a wobbly leg. Recurring hygiene revenue is what makes a dental group feel like an annuity rather than a gamble, and annuities command premiums. The groups that hold their price have built recall that survives a single resignation, because patients return to the practice, not to a specific hygienist. When your recurring revenue is anchored to systems and reputation instead of individuals, the buyer can model it forward with confidence, and confidence is what you are actually selling.

What does a declining recall base tell a buyer about future cash flow?

It tells them the annuity is shrinking, and the annuity is what they came for. A dental group's value rests heavily on the patients who come back, because recurring visits are the most predictable line in the model. When your recall base is thinning, a buyer reads it as future cash flow eroding before they even take over, and they price accordingly. The patients most worth keeping are the high-value ones, and demand for high-value treatment is rising: ortho is growing 5.1% a year at around $5,500 a case. If your practice is not capturing its share of that growing demand, you are not just flat, you are losing ground against a rising market, and a buyer notices the gap between what your area generates and what you retain. You see a stable list. An acquirer sees whether that list is growing or quietly aging out. A declining recall base caps the offer because it turns your strongest asset, predictability, into your biggest question mark. The groups that sell at a premium can show a recall base that is holding or growing, not one running on fumes.

What is the one red flag that quietly caps every offer you receive?

Invisibility. Not weak numbers, not a soft month, but the absence of a clear, findable position in the market that a patient can act on without knowing your name. Every other red flag on this list is a symptom of it. Declining new patients, owner-concentrated referrals, thin reputation, poor AI readiness: each one traces back to a practice that is hard to find and hard to choose at the moment of decision. In a $179.4 billion market moving fast toward consolidation, a buyer's core question never changes: will this revenue still be here after the seller leaves. An invisible practice cannot answer yes, no matter how strong last year looked. You experience invisibility as a slow leak you have learned to live with. A buyer experiences it as the reason to hold back a full offer. The practices that sell at a premium are not the ones that worked hardest. They are the ones a patient can find and choose in the moment that matters, which is what makes their revenue survive the handover. You can see where you stand as a visible, findable practice before a buyer does.

Here is the part that should sit with you tonight. Positioning clarity is not a pre-sale cosmetic. It is the single thing that decides whether your revenue reads as durable or fragile in a diligence room, and it works exactly the same way for Google Maps ranking and AI search as it does for your valuation. A practice that clearly signals its value shows up when patients search, holds its demand through a transition, and earns the premium. A practice with invisible positioning stays invisible to patients, to the engines, and to the buyer, regardless of effort or spend. The number on your offer is a mirror. It reflects how findable and how defensible your revenue really is.